Alexa Siddon, MD
Associate Professor Term; Hematopathology Fellowship Director, Laboratory Medicine; Director, Molecular Diagnostics Laboratory, Laboratory Medicine; Director, Flow Cytometry, Laboratory Medicine; Associate Director, Hematology Laboratory, Laboratory Medicine
Research & Publications
Biography
News
Locations
Coauthors
Selected Publications
- Myelodysplastic SyndromesSiddon A. Myelodysplastic Syndromes. Clinics In Laboratory Medicine 2023, 43: i. DOI: 10.1016/s0272-2712(23)00095-1.
- Advances in Myelodysplastic SyndromesSiddon A. Advances in Myelodysplastic Syndromes. Clinics In Laboratory Medicine 2023, 43: xiii-xiv. PMID: 37865512, DOI: 10.1016/j.cll.2023.08.015.
- Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53Siddon A, Weinberg O. Diagnosis and Classification of Myelodysplastic Syndromes with Mutated TP53. Clinics In Laboratory Medicine 2023, 43: 607-614. PMID: 37865506, DOI: 10.1016/j.cll.2023.07.004.
- Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group reportLee T, Aisner D, David M, Eno C, Gagan J, Gocke C, Guseva N, Haley L, Jajosky A, Jones D, Mansukhani M, Mroz P, Murray S, Newsom K, Paulson V, Roy S, Rushton C, Segal J, Senaratne T, Siddon A, Starostik P, Van Ziffle J, Wu D, Xian R, Yohe S, Kim A. Current clinical practices and challenges in molecular testing: a GOAL Consortium Hematopathology Working Group report. Blood Advances 2023, 7: 4599-4607. PMID: 37236162, PMCID: PMC10425685, DOI: 10.1182/bloodadvances.2023010149.
- Helicobacter pylori–negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: A clinicopathologic analysisGu S, Siddon A, Huntington S, Jain D. Helicobacter pylori–negative mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: A clinicopathologic analysis. American Journal Of Clinical Pathology 2023, 160: 612-619. PMID: 37556379, PMCID: PMC10691190, DOI: 10.1093/ajcp/aqad088.
- Molecular Techniques and Gene Mutations in Myelodysplastic SyndromesMendoza H, Siddon A. Molecular Techniques and Gene Mutations in Myelodysplastic Syndromes. Clinics In Laboratory Medicine 2023, 43: 549-563. PMID: 37865502, DOI: 10.1016/j.cll.2023.06.002.
- Molecular findings in myeloid neoplasmsTran T, Siddon A. Molecular findings in myeloid neoplasms. International Journal Of Laboratory Hematology 2023, 45: 442-448. PMID: 37345257, DOI: 10.1111/ijlh.14118.
- Optimizing Donor Chimerism Threshold for Next-Generation Sequencing Monitoring of Measurable Residual Disease Post-Allogeneic Stem Cell Transplantation for Myeloid NeoplasmsPuzo C, Tormey C, Rinder H, Siddon A. Optimizing Donor Chimerism Threshold for Next-Generation Sequencing Monitoring of Measurable Residual Disease Post-Allogeneic Stem Cell Transplantation for Myeloid Neoplasms. Transplantation And Cellular Therapy 2023, 29: 459.e1-459.e4. PMID: 37062510, DOI: 10.1016/j.jtct.2023.04.005.
- Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Groupde Cap M, Wu L, Hirt C, Pihan G, Patel S, Tam W, Bueso-Ramos C, Kanagal-Shamanna R, Raess P, Siddon A, Narayanan D, Morgan E, Pinkus G, Mason E, Hsi E, Rogers H, Toth L, Foucar K, Hurwitz S, Bagg A, Rets A, George T, Orazi A, Arber D, Hasserjian R, Weinberg O, Group F. Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. Leukemia & Lymphoma 2023, 64: 972-980. PMID: 36960680, DOI: 10.1080/10428194.2023.2185091.
- Quantitative Risk for Single-Positive Lupus Anticoagulant Results With Different AnticoagulantsKhan W, Tormey C, Rinder H, Siddon A. Quantitative Risk for Single-Positive Lupus Anticoagulant Results With Different Anticoagulants. American Journal Of Clinical Pathology 2023, 159: 417-419. PMID: 36940149, DOI: 10.1093/ajcp/aqac183.
- An interactive e-learning module on peripheral blood smear analysis is an effective option for teaching pathology trainees.Moore M, Courville E, Prakash S, Brown L, Beck R, Qualtieri J, Siddon A, Wake L. An interactive e-learning module on peripheral blood smear analysis is an effective option for teaching pathology trainees. American Journal Of Clinical Pathology 2023, 160: 150-156. PMID: 36905942, DOI: 10.1093/ajcp/aqad014.
- “Double‐hit” ineffective erythropoiesis—concurrent β‐thalassemia with α‐gene triplication and myelodysplastic syndrome with SF3B1 mutationChen P, Gorshein E, Tormey C, Siddon A, Perincheri S. “Double‐hit” ineffective erythropoiesis—concurrent β‐thalassemia with α‐gene triplication and myelodysplastic syndrome with SF3B1 mutation. American Journal Of Hematology 2023, 98: 984-988. PMID: 36688500, DOI: 10.1002/ajh.26856.
- Recent Advances in the Classification of Gynecological Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book".Parkash V, Aisagbonhi O, Riddle N, Siddon A, Panse G, Fadare O. Recent Advances in the Classification of Gynecological Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book". Archives Of Pathology & Laboratory Medicine 2023, 147: 1204-1216. PMID: 36596270, DOI: 10.5858/arpa.2022-0166-ra.
- Recognizing the microgranular variant of acute promyelocytic leukemia when considering leukapheresisGisriel S, Chen P, Tormey C, Siddon A. Recognizing the microgranular variant of acute promyelocytic leukemia when considering leukapheresis. Transfusion 2022, 63: 277-278. PMID: 36426743, DOI: 10.1111/trf.17195.
- NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotypeRamia de Cap M, Wu L, Pihan G, Narayanan D, Morgan E, Pinkus G, Cin P, Hurwitz S, Bagg A, Patel S, Tam W, Ouseph M, Gagan J, Madanat Y, Siddon A, Raess P, Rogers H, Bueso-Ramos C, Kanagal-Shamanna R, Kurzer J, Arber D, Hasserjian R, Weinberg O. NPM1 mutations may be associated with adverse outcome in the setting of myeloid neoplasms with complex karyotype. Leukemia Research 2022, 123: 106965. PMID: 36332291, DOI: 10.1016/j.leukres.2022.106965.
- Autoimmune hemolytic anemias and paroxysmal nocturnal hemoglobinuriaTormey C, Siddon A. Autoimmune hemolytic anemias and paroxysmal nocturnal hemoglobinuria. 2022, 346-363. DOI: 10.1002/9781119719809.ch31.
- Automated analysers underestimate atypical basophil count in myeloid neoplasmsShah HP, Tormey CA, Siddon AJ. Automated analysers underestimate atypical basophil count in myeloid neoplasms. International Journal Of Laboratory Hematology 2022, 44: 831-836. PMID: 35609868, DOI: 10.1111/ijlh.13882.
- TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AMLWeinberg OK, Siddon A, Madanat Y, Gagan J, Arber DA, Dal Cin P, Narayanan D, Ouseph MM, Kurzer JH, Hasserjian RP. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML. Blood Advances 2022, 6: 2847-2853. PMID: 35073573, PMCID: PMC9092405, DOI: 10.1182/bloodadvances.2021006239.
- CD5‐positive, CD10‐positive large B‐cell lymphoma with t(14;18) mimicking acute leukemiaGisriel SD, Jacobs JW, Siddon AJ. CD5‐positive, CD10‐positive large B‐cell lymphoma with t(14;18) mimicking acute leukemia. International Journal Of Laboratory Hematology 2022, 44: 698-699. PMID: 35166437, DOI: 10.1111/ijlh.13812.
- Concurrent COVID-19 and babesiosis in an older, splenectomized patientJacobs JW, Siddon AJ. Concurrent COVID-19 and babesiosis in an older, splenectomized patient. Blood 2021, 138: 2154. PMID: 34821934, PMCID: PMC8614064, DOI: 10.1182/blood.2021013947.
- The Lab as a Driver of Quality in the Preanalytical Realm: The Case of Technologist-Assisted Bone Marrow BiopsiesSiddon AJ, Kroft SH. The Lab as a Driver of Quality in the Preanalytical Realm: The Case of Technologist-Assisted Bone Marrow Biopsies. American Journal Of Clinical Pathology 2021, 157: 480-481. PMID: 34788363, DOI: 10.1093/ajcp/aqab180.
- Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory TestingEaswar A, Siddon AJ. Genetic Landscape of Myeloproliferative Neoplasms with an Emphasis on Molecular Diagnostic Laboratory Testing. Life 2021, 11: 1158. PMID: 34833034, PMCID: PMC8625510, DOI: 10.3390/life11111158.
- Development of anti-Jk3 associated with silenced Kidd antigen expression and a novel single nucleotide variant of the JK geneManrai PA, Siddon AJ, Hager KM, Hendrickson JE, Keller MA, Tormey CA. Development of anti-Jk3 associated with silenced Kidd antigen expression and a novel single nucleotide variant of the JK gene. Immunohematology 2021, 37: 109-112. PMID: 34591379, DOI: 10.21307/immunohematology-2021-015.
- Laboratory evaluation and prognostication among adults and children with CEBPA‐mutant acute myeloid leukemiaMendoza H, Podoltsev NA, Siddon AJ. Laboratory evaluation and prognostication among adults and children with CEBPA‐mutant acute myeloid leukemia. International Journal Of Laboratory Hematology 2021, 43: 86-95. PMID: 34288448, DOI: 10.1111/ijlh.13517.
- Clinical and Molecular Approach to Adult-Onset, Neoplastic MonocytosisShallis RM, Siddon AJ, Zeidan AM. Clinical and Molecular Approach to Adult-Onset, Neoplastic Monocytosis. Current Hematologic Malignancy Reports 2021, 16: 276-285. PMID: 33890194, DOI: 10.1007/s11899-021-00632-6.
- Behind the scenes with basophils: an emerging therapeutic targetShah H, Eisenbarth S, Tormey CA, Siddon AJ. Behind the scenes with basophils: an emerging therapeutic target. Immunotherapy Advances 2021, 1: ltab008. PMID: 35919744, PMCID: PMC9327101, DOI: 10.1093/immadv/ltab008.
- The utility and limitations of B- and T-cell gene rearrangement studies in evaluating lymphoproliferative disordersMendoza H, Tormey CA, Rinder HM, Howe JG, Siddon AJ. The utility and limitations of B- and T-cell gene rearrangement studies in evaluating lymphoproliferative disorders. Pathology 2020, 53: 157-165. PMID: 33358756, DOI: 10.1016/j.pathol.2020.09.024.
- A case of acute myeloid leukemia with unusual germline CEBPA mutation: lessons learned about mutation detection, location, and penetranceMendoza H, Chen PH, Pine AB, Siddon AJ, Bale AE, Gowda L, Killie A, Richards J, Varin-Tremblay C, Kloss R, Podoltsev NA. A case of acute myeloid leukemia with unusual germline CEBPA mutation: lessons learned about mutation detection, location, and penetrance. Leukemia & Lymphoma 2020, 62: 1251-1254. PMID: 33345654, DOI: 10.1080/10428194.2020.1861276.
- Progressive Dyspnea and Hypoxemia With Diffuse Pulmonary Infiltrates in a Previously Healthy WomanMainardi AS, Siddon AJ, Bader AS, Hilbert J. Progressive Dyspnea and Hypoxemia With Diffuse Pulmonary Infiltrates in a Previously Healthy Woman. CHEST Journal 2020, 158: e327-e334. PMID: 33280778, DOI: 10.1016/j.chest.2020.07.009.
- A complex karyotype and a genetic mutation in acute myeloid leukaemiaBewersdorf JP, Siddon A, DiAdamo A, Zeidan AM. A complex karyotype and a genetic mutation in acute myeloid leukaemia. The Lancet 2020, 396: 2018. PMID: 33341145, DOI: 10.1016/s0140-6736(20)32543-5.
- Factor V activity in apheresis platelets: Implications for management of FV deficiencyGupta GK, Hendrickson JE, Bahel P, Siddon AJ, Rinder HM, Tormey CA. Factor V activity in apheresis platelets: Implications for management of FV deficiency. Transfusion 2020, 61: 405-409. PMID: 33166428, DOI: 10.1111/trf.16179.
- Criteria for Ordering Myeloid Neoplasm Next-Generation Sequencing to Optimize Personalized Patient Care and CostGisriel S, Rinder H, Siddon A. Criteria for Ordering Myeloid Neoplasm Next-Generation Sequencing to Optimize Personalized Patient Care and Cost. Blood 2020, 136: 39-40. DOI: 10.1182/blood-2020-139035.
- Assessment of Factor V Activity in Apheresis Platelet Units: Implications for Management of FV DeficiencyGupta G, Hendrickson J, Bahel P, Siddon A, Rinder H, Tormey C. Assessment of Factor V Activity in Apheresis Platelet Units: Implications for Management of FV Deficiency. American Journal Of Clinical Pathology 2020, 154: s6-s7. DOI: 10.1093/ajcp/aqaa137.011.
- Monocytic Acute Myeloid Leukemias with KM2TA Translocations to Chromosome 17q that May Clinically Mimic Acute Promyelocytic LeukemiaBalbuena-Merle RI, Tormey CA, DiAdamo A, Rinder HM, Siddon AJ. Monocytic Acute Myeloid Leukemias with KM2TA Translocations to Chromosome 17q that May Clinically Mimic Acute Promyelocytic Leukemia. Lab Medicine 2020, 52: 290-296. PMID: 32984885, DOI: 10.1093/labmed/lmaa078.
- Evaluation of Positive B- and T-Cell Gene Rearrangement Studies in Patients With Negative Morphology, Flow Cytometry, and ImmunohistochemistryMendoza H, Tormey CA, Siddon AJ. Evaluation of Positive B- and T-Cell Gene Rearrangement Studies in Patients With Negative Morphology, Flow Cytometry, and Immunohistochemistry. Archives Of Pathology & Laboratory Medicine 2020, 145: 227-230. PMID: 32886749, DOI: 10.5858/arpa.2019-0663-oa.
- Impact of intra-tumoral heterogeneity detected by next-generation sequencing on acute myeloid leukemia survivalSchulz WL, Rinder HM, Durant TJS, Tormey CA, Torres R, Smith BR, Hager KM, Howe JG, Siddon AJ. Impact of intra-tumoral heterogeneity detected by next-generation sequencing on acute myeloid leukemia survival. Leukemia & Lymphoma 2020, 61: 3269-3271. PMID: 32715805, DOI: 10.1080/10428194.2020.1797016.
- How I Diagnose Low-Grade Myelodysplastic SyndromesSiddon AJ, Hasserjian RP. How I Diagnose Low-Grade Myelodysplastic Syndromes. American Journal Of Clinical Pathology 2020, 154: 5-14. PMID: 32458977, DOI: 10.1093/ajcp/aqaa046.
- How I DiagnoseSiddon AJ, Czader M. How I Diagnose. American Journal Of Clinical Pathology 2020, 154: 4-4. PMID: 32458973, DOI: 10.1093/ajcp/aqaa034.
- Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience*Bewersdorf JP, Shallis RM, Gowda L, Wei W, Hager K, Isufi I, Kim TK, Pillai MM, Seropian S, Podoltsev NA, Gore SD, Siddon AJ, Zeidan AM. Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: a single center experience*. Leukemia & Lymphoma 2020, 61: 2180-2190. PMID: 32362171, PMCID: PMC7603787, DOI: 10.1080/10428194.2020.1759051.
- Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization statusBalbuena-Merle R, Santhanakrishnan M, Devine L, Gibb DR, Tormey CA, Siddon AJ, Curtis SA, Gallagher PG, Weinstein JS, Hendrickson JE. Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization status. Transfusion And Apheresis Science 2020, 59: 102778. PMID: 32439490, PMCID: PMC7483805, DOI: 10.1016/j.transci.2020.102778.
- The Development and Implementation of a Novel Electronic Consult System by a Laboratory Medicine Service: Experience From the First 2 Years of UseStendahl K, Siddon AJ, Peaper DR, Hauser RG, Campbell S, Tormey CA. The Development and Implementation of a Novel Electronic Consult System by a Laboratory Medicine Service: Experience From the First 2 Years of Use. Archives Of Pathology & Laboratory Medicine 2020, 145: 75-81. PMID: 33367659, DOI: 10.5858/arpa.2019-0267-oa.
- Isolated trisomy 11 in patients with acute myeloid leukemia – is the prognosis not as grim as previously thought?*Bewersdorf JP, Shallis RM, Diadamo A, Gowda L, Podoltsev NA, Siddon A, Zeidan AM. Isolated trisomy 11 in patients with acute myeloid leukemia – is the prognosis not as grim as previously thought?*. Leukemia & Lymphoma 2020, 61: 2254-2257. PMID: 32338096, PMCID: PMC7485109, DOI: 10.1080/10428194.2020.1755858.
- Investigation of increased platelet alloimmunization screening in the era of pathogen‐reduced platelets treated with psoralen/UV lightHendrickson JE, Mendoza H, Ross R, Siddon AJ, Gowda L, Hauser RG, Schulz WL, Tormey CA. Investigation of increased platelet alloimmunization screening in the era of pathogen‐reduced platelets treated with psoralen/UV light. Transfusion 2020, 60: 650-651. PMID: 32128834, DOI: 10.1111/trf.15691.
- Use of B-Cell Gene Rearrangement Studies to Establish Clonality in Non-producer Non-secretory Multiple MyelomaMendoza H, Tormey CA, Siddon AJ. Use of B-Cell Gene Rearrangement Studies to Establish Clonality in Non-producer Non-secretory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia 2019, 20: e18-e21. PMID: 31711890, DOI: 10.1016/j.clml.2019.10.012.
- DUSP22-IRF4 rearrangement in AIDS-associated ALK-negative anaplastic large cell lymphomaWang M, Kibbi N, Ring N, Siddon A, Foss F, Totonchy M. DUSP22-IRF4 rearrangement in AIDS-associated ALK-negative anaplastic large cell lymphoma. BMJ Case Reports 2019, 12: e230641. PMID: 31570354, PMCID: PMC6768350, DOI: 10.1136/bcr-2019-230641.
- PT and aPTT Are Not Predictors of Thromboembolic EventsShervinrad M, Tormey C, Siddon A. PT and aPTT Are Not Predictors of Thromboembolic Events. American Journal Of Clinical Pathology 2019, 152: s36-s36. DOI: 10.1093/ajcp/aqz112.068.
- Evaluation of Positive T- and B-Cell Gene Rearrangement Studies Among Patients Without a Definitive Diagnosis by Other AssaysMendoza H, Tormey C, Siddon A. Evaluation of Positive T- and B-Cell Gene Rearrangement Studies Among Patients Without a Definitive Diagnosis by Other Assays. American Journal Of Clinical Pathology 2019, 152: s35-s36. DOI: 10.1093/ajcp/aqz112.067.
- Acute myeloid leukemia presenting as bilateral adrenal hemorrhageMendoza H, Podoltsev NA, Siddon AJ, Gnanapandithan K. Acute myeloid leukemia presenting as bilateral adrenal hemorrhage. Annals Of Hematology 2019, 98: 2421-2423. PMID: 31446457, DOI: 10.1007/s00277-019-03788-7.
- Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell diseaseBalbuena‐Merle R, Curtis SA, Devine L, Gibb DR, Karafin MS, Luckey CJ, Tormey CA, Siddon AJ, Roberts JD, Hendrickson JE. Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease. Transfusion 2019, 59: 3219-3227. PMID: 31355970, PMCID: PMC7075520, DOI: 10.1111/trf.15463.
- Molecular and Cytogenetic Education in Hematopathology FellowshipSoma LA, Kovach AE, Siddon AJ, Beck R, Gibson SE, Swerdlow SH, Kim AS, Wu D, Jones D, Cook JR, Prakash S, Rosado F, Crane G, Bradley K, Weinberg OK, Sargent RL. Molecular and Cytogenetic Education in Hematopathology Fellowship. American Journal Of Clinical Pathology 2019, 152: 438-445. PMID: 31141139, DOI: 10.1093/ajcp/aqz048.
- Chapter Six The chemical and laboratory investigation of hemolysisSiddon AJ, Tormey CA. Chapter Six The chemical and laboratory investigation of hemolysis. 2019, 89: 215-258. PMID: 30797470, DOI: 10.1016/bs.acc.2018.12.006.
- 64 Platelet Transfusion MedicineSiddon A, Tormey C, Snyder E. 64 Platelet Transfusion Medicine. 2019, 1137-1159. DOI: 10.1016/b978-0-12-813456-6.00064-3.
- Pocket Guide to Diagnostic HematopathologyHudnall S, Much M, Siddon A. Pocket Guide to Diagnostic Hematopathology. 2019 DOI: 10.1007/978-3-030-10630-0.
- Modified approach to fibrinogen replacement in the setting of dysfibrinogenaemiaChandler JB, Siddon AJ, Bahel P, Torres R, Rinder HM, Tormey CA. Modified approach to fibrinogen replacement in the setting of dysfibrinogenaemia. Journal Of Clinical Pathology 2018, 72: 177. PMID: 30463936, DOI: 10.1136/jclinpath-2018-205438.
- Delayed haemolytic and serologic transfusion reactionsSiddon AJ, Kenney BC, Hendrickson JE, Tormey CA. Delayed haemolytic and serologic transfusion reactions. Current Opinion In Hematology 2018, 25: 459-467. PMID: 30124474, DOI: 10.1097/moh.0000000000000462.
- False-Positive Light Chain Clonal Restriction by Flow Cytometry in Patients Treated With AlemtuzumabChen PP, Tormey CA, Eisenbarth SC, Torres R, Richardson SS, Rinder HM, Smith BR, Siddon AJ. False-Positive Light Chain Clonal Restriction by Flow Cytometry in Patients Treated With Alemtuzumab. American Journal Of Clinical Pathology 2018, 151: 154-163. PMID: 30307483, DOI: 10.1093/ajcp/aqy129.
- ACUTE HYPOXEMIA DUE TO PULMONARY LEUKEMIC INFILTRATES IN A PATIENT WITH NEWLY DIAGNOSED T-CELL PRO-LYMPHOCYTIC LEUKEMIAMAINARDI A, HILBERT J, BADER A, SIDDON A. ACUTE HYPOXEMIA DUE TO PULMONARY LEUKEMIC INFILTRATES IN A PATIENT WITH NEWLY DIAGNOSED T-CELL PRO-LYMPHOCYTIC LEUKEMIA. CHEST Journal 2018, 154: 414a. DOI: 10.1016/j.chest.2018.08.378.
- Visualization of bacterial contamination in an apheresis platelet unitSiddon AJ, Snyder EL, Tormey CA. Visualization of bacterial contamination in an apheresis platelet unit. Journal Of Clinical Apheresis 2018, 33: 671-672. PMID: 30242893, DOI: 10.1002/jca.21649.
- Be careful of the masquerades: differentiating secondary myelodysplasia from myelodysplastic syndromes in clinical practiceShallis RM, Xu ML, Podoltsev NA, Curtis SA, Considine BT, Khanna SR, Siddon AJ, Zeidan AM. Be careful of the masquerades: differentiating secondary myelodysplasia from myelodysplastic syndromes in clinical practice. Annals Of Hematology 2018, 97: 2333-2343. PMID: 30109425, DOI: 10.1007/s00277-018-3474-7.
- Morphology and flow cytometry of atypical basophilsTormey CA, Siddon AJ. Morphology and flow cytometry of atypical basophils. Blood 2018, 132: 552. PMID: 30072417, DOI: 10.1182/blood-2018-05-850073.
- Hematopoietic Stem Cell Donor Selection and Graft-Versus-Host DiseaseSiddon A, Tormey C. Hematopoietic Stem Cell Donor Selection and Graft-Versus-Host Disease. 2018, 105-117. DOI: 10.1007/978-3-319-89866-7_7.
- R634W KIT Mutation in an Adult With Systemic Mastocytosis.Astle JM, Rose MG, Racke FK, Tormey CA, Siddon AJ. R634W KIT Mutation in an Adult With Systemic Mastocytosis. Lab Medicine 2017, 48: 253-257. PMID: 28520972, DOI: 10.1093/labmed/lmx026.
- Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in miceLiu J, Santhanakrishnan M, Natarajan P, Gibb DR, Eisenbarth SC, Tormey CA, Siddon AJ, Stowell SR, Branch DR, Hendrickson JE. Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice. Blood 2016, 128: 3159-3168. PMID: 27688803, PMCID: PMC5201095, DOI: 10.1182/blood-2016-06-724732.
- A Modified Approach to Fibrinogen Replacement in the Setting of DysfibrinogenemiaChandler J, Bahel P, Siddon A, Torres R, Rinder H, Tormey C. A Modified Approach to Fibrinogen Replacement in the Setting of Dysfibrinogenemia. American Journal Of Clinical Pathology 2016, 146: 326. DOI: 10.1093/ajcp/aqw160.005.
- Successful Use of Four Factor-Prothrombin Complex Concentrate for Congenital Factor X Deficiency in the Setting of NeurosurgerySiddon AJ, Tormey CA. Successful Use of Four Factor-Prothrombin Complex Concentrate for Congenital Factor X Deficiency in the Setting of Neurosurgery. Lab Medicine 2016, 47: e35-e37. PMID: 27378481, PMCID: PMC4985779, DOI: 10.1093/labmed/lmw037.
- Multi‐system complications of hypereosinophiliaStahl M, Mohareb AM, Lee AI, Federman DG, Siddon AJ, Spelman J. Multi‐system complications of hypereosinophilia. American Journal Of Hematology 2016, 91: 444-447. PMID: 26700720, DOI: 10.1002/ajh.24283.
- Use of application containers and workflows for genomic data analysisSchulz WL, Durant TJ, Siddon AJ, Torres R. Use of application containers and workflows for genomic data analysis. Journal Of Pathology Informatics 2016, 7: 53. PMID: 28163975, PMCID: PMC5248400, DOI: 10.4103/2153-3539.197197.
- Impact of Molecular Clonality on Survival in Acute Myeloid LeukemiaSchulz W, Durant T, Rinder H, Tormey C, Torres R, Smith B, Hager K, Howe J, Siddon A. Impact of Molecular Clonality on Survival in Acute Myeloid Leukemia. Blood 2015, 126: 1385. DOI: 10.1182/blood.v126.23.1385.1385.
- Pathology Consultation on Gene Mutations in Acute Myeloid LeukemiaZiai JM, Siddon AJ. Pathology Consultation on Gene Mutations in Acute Myeloid Leukemia. American Journal Of Clinical Pathology 2015, 144: 539-554. PMID: 26386075, DOI: 10.1309/ajcp77zfpuqgygwy.
- Hemoglobinopathy Screening in a 15-Year-old Patient With AnemiaHonarpisheh H, Hogan M, Rinder HM, Siddon AJ. Hemoglobinopathy Screening in a 15-Year-old Patient With Anemia. Journal Of Pediatric Hematology/Oncology 2015, 37: 472-473. PMID: 26181419, DOI: 10.1097/mph.0000000000000357.
- Is thrombin time too sensitive to dabigatran anticoagulation for clinical decision making in the setting of acute hemorrhage?Siddon AJ, Rinder HM, Hendrickson JE, Tormey CA. Is thrombin time too sensitive to dabigatran anticoagulation for clinical decision making in the setting of acute hemorrhage? Annals Of Hematology 2015, 94: 1413-1414. PMID: 26027859, DOI: 10.1007/s00277-015-2406-z.
- Catastrophic basilar artery leukostasis in the setting of acute myeloid leukemiaRaad R, Tormey CA, Siddon AJ. Catastrophic basilar artery leukostasis in the setting of acute myeloid leukemia. Transfusion 2014, 54: 970-970. PMID: 24724788, DOI: 10.1111/trf.12384.
- Cardiac FDG-PET to Assess Sarcoidosis in a Cardiac AllograftChen A, Khanna P, Siddon A, Russell R. Cardiac FDG-PET to Assess Sarcoidosis in a Cardiac Allograft. Clinical Nuclear Medicine 2014, 39: 54-56. PMID: 23603601, DOI: 10.1097/rlu.0b013e318279ffc7.
- Pathology Consultation on Evaluating Prognosis in Incidental Monoclonal Lymphocytosis and Chronic Lymphocytic LeukemiaSiddon AJ, Rinder HM. Pathology Consultation on Evaluating Prognosis in Incidental Monoclonal Lymphocytosis and Chronic Lymphocytic Leukemia. American Journal Of Clinical Pathology 2013, 139: 708-712. PMID: 23690112, DOI: 10.1309/ajcplir4gzwx3xka.
- Human herpesvirus 6 positive Reed–Sternberg cells in nodular sclerosis Hodgkin lymphomaSiddon A, Lozovatsky L, Mohamed A, Hudnall SD. Human herpesvirus 6 positive Reed–Sternberg cells in nodular sclerosis Hodgkin lymphoma. British Journal Of Haematology 2012, 158: 635-643. PMID: 22757777, DOI: 10.1111/j.1365-2141.2012.09206.x.
- Normalized CCND1 expression has prognostic value in mantle cell lymphomaSiddon AJ, Torres R, Rinder HM, Smith BR, Howe JG, Tormey CA. Normalized CCND1 expression has prognostic value in mantle cell lymphoma. British Journal Of Haematology 2012, 158: 551-553. PMID: 22671703, DOI: 10.1111/j.1365-2141.2012.09181.x.
- Glial Heterotopia of the Uterine Cervix: DNA Genotyping Confirmation of its Fetal OriginSiddon A, Hui P. Glial Heterotopia of the Uterine Cervix: DNA Genotyping Confirmation of its Fetal Origin. International Journal Of Gynecological Pathology 2010, 29: 394-397. PMID: 20567155, DOI: 10.1097/pgp.0b013e3181c5a7e8.